Parexel International Corporation

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Commitment removed

SBTI ID

40011404

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

15/08/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Parexel International Corporation commits to reduce absolute scope 1 GHG emissions 42% by 2030 from 2022 base year. Parexel International Corporation also commits to continue active annual sourcing of 100% renewable electricity through 2030. Parexel International Corporation further commits to reduce absolute scope 3 GHG emissions 25% by 2030 from 2022 base year.

Net-Zero

Statut

Commitment removed
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

03/11/2022

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

US6994621075

LEI

549300GCZVUYB6P2OA17

Note

Expired commitment

Source : Science Based Targets initiative | Données publiques